Ancora Advisors’s Envoy Medical COCH Stock Holding History

Ancora Advisors’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63,899	Closed	-$645K	–	1970
2022 Q4	$645K	Sell	63,899 -8,800	-12%	-$87.5K	0.02%	431
2022 Q3	$715K	Hold	72,699	–	–	0.02%	426
2022 Q2	$712K	Hold	72,699	–	–	0.02%	446
2022 Q1	$710K	Buy	72,699 +1,013	+1%	+$9.86K	0.02%	460
2021 Q4	$699K	Hold	71,686	–	–	0.02%	472
2021 Q3	$696K	Hold	71,686	–	–	0.02%	468
2021 Q2	$698K	Buy	+71,686	New	+$697K	0.02%	467

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ancora Advisors's COCH Position: Q1 2023 in Review

Ancora Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 63,899 shares — an estimated $645K sold.

Ancora Advisors first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $715K in Q3 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Ancora Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Ancora Advisors sold 63,899 Envoy Medical shares in Q1 2023, an estimated $645K.
Ancora Advisors first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Ancora Advisors's Envoy Medical position peaked at $715K in Q3 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.